413 FIBROTEST (FT) VALUE INDEPENDENTLY PREDICTS EARLY (EVR) AND SUSTAINED VIROLOGICAL RESPONSE (SVR) IN NON-RESPONDER PATIENTS RE-TREATED WITH PEGYLATED INTERFERON ALFA-2B (PEG-2B) AND RIBAVIRIN IN EPIC3

Authors :: Poynard, T.
Schiff, E.R.
Terg, R.
Moreno-Otero, R.
Flamm, S.L.
Schmidt, W.
Berg, T.
Goncales, F.L.
Heathcote, J.E.
Diago, M.
McGarrity, T.
Bedossa, P.
Zhou, H.
Mukhopadhyay, P.
Griffel, L.H.
Burroughs, M.
Brass, C.A.
Albrecht, J.K.
Source :: Journal of Hepatology. Apr2009 Supplement 1, Vol. 50, pS156-S156. 1p.
Publication Year :: 2009

Full Text Access

Tools